Literature DB >> 20417517

The ALDH2 Glu504Lys polymorphism is associated with coronary artery disease in Han Chinese: Relation with endothelial ADMA levels.

Yi-Jie Guo1, Lei Chen, Yong-Ping Bai, Ling Li, Ji Sun, Guo-Gang Zhang, Tian-Lun Yang, Jian Xia, Yuan-Jian Li, Xiao-Ping Chen.   

Abstract

OBJECTIVES: We studied the association between mitochondrial aldehyde dehydrogenase (ALDH2) Glu504Lys (rs671 or ALDH2*2) polymorphism and coronary artery disease (CAD), and sought to clarify the mechanisms underlying this association.
METHODS: The ALDH2 rs671 polymorphism was genotyped in 417 CAD patients and 448 age- and gender-matched controls. All participants were Han Chinese. Human umbilical vein endothelial cells (HUVECs) isolated from 11 human umbilical cords were genotyped, cultured, and exposed to angiotensin II (Ang II, 10(-7)-10(-5)mol/L). Dimethylarginine dimethylaminohydrolase 1 (DDAH1) mRNA expression levels were determined by real-time PCR. Levels of asymmetric dimethylarginine (ADMA) in culture media and cell lysates were determined by high performance liquid chromatography-mass spectrometry (HPLC-MS).
RESULTS: The frequency of carriers of the ALDH2 rs671 A allele (GA+AA) was significantly higher in patients with CAD (47.5%) than in controls (35.0%, p=0.0002). After adjustment for potential confounders, the odds ratio (OR) for CAD for carriers of the rs671 A allele was 1.85 (95% confidence interval [CI]: 1.38-2.49, p=0.00005) in the entire study cohort, and 1.95 (95% CI: 1.40-2.70, p=0.00007) in non-drinkers. In non-drinking controls, the homozygous rs671 AA genotype was associated with significantly lower high-density lipoprotein cholesterol (HDL-C) concentrations compared with rs671 GG homozygotes (p=0.015). HUVEC cells homozygous for the G allele of rs671 showed a significantly higher DDAH1 mRNA expression and lower intracellular ADMA levels compared with heterozygous GA cells (p<0.05, respectively). In homozygous GG cells, high concentrations of Ang II (10(-5)mol/L) decreased DDAH1 mRNA expression and increased intracellular ADMA concentrations.
CONCLUSIONS: The rs671 polymorphism of ALDH2 is associated with CAD in Han Chinese, possibly by influencing HDL-C levels and endothelial ADMA levels. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20417517     DOI: 10.1016/j.atherosclerosis.2010.03.030

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  27 in total

Review 1.  Mitochondrial reactive oxygen species at the heart of the matter: new therapeutic approaches for cardiovascular diseases.

Authors:  Opher S Kornfeld; Sunhee Hwang; Marie-Hélène Disatnik; Che-Hong Chen; Nir Qvit; Daria Mochly-Rosen
Journal:  Circ Res       Date:  2015-05-22       Impact factor: 17.367

2.  Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system.

Authors:  Antje D Ebert; Kazuki Kodo; Ping Liang; Haodi Wu; Bruno C Huber; Johannes Riegler; Jared Churko; Jaecheol Lee; Patricia de Almeida; Feng Lan; Sebastian Diecke; Paul W Burridge; Joseph D Gold; Daria Mochly-Rosen; Joseph C Wu
Journal:  Sci Transl Med       Date:  2014-09-24       Impact factor: 17.956

3.  Correlations of ALDH2 rs671 and C12orf30 rs4767364 polymorphisms with increased risk and prognosis of esophageal squamous cell carcinoma in the Kazak and Han populations in Xinjiang province.

Authors:  Pan Liu; Hua-Rong Zhao; Fang Li; Lei Zhang; Hua Zhang; Wen-Ran Wang; Rui Mao; Wei-Peng Su; Yang Zhang; Yong-Xing Bao
Journal:  J Clin Lab Anal       Date:  2017-05-02       Impact factor: 2.352

Review 4.  Induced pluripotent stem cells: at the heart of cardiovascular precision medicine.

Authors:  Ian Y Chen; Elena Matsa; Joseph C Wu
Journal:  Nat Rev Cardiol       Date:  2016-03-24       Impact factor: 32.419

5.  Aldehyde dehydrogenase-2 protects against myocardial infarction-related cardiac fibrosis through modulation of the Wnt/β-catenin signaling pathway.

Authors:  Xinjun Zhao; Yue Hua; Hongmei Chen; Haiyu Yang; Tao Zhang; Guiqiong Huang; Huijie Fan; Zhangbin Tan; Xiaofang Huang; Bin Liu; Yingchun Zhou
Journal:  Ther Clin Risk Manag       Date:  2015-09-11       Impact factor: 2.423

6.  Association between aldehyde dehydrogenase 2 polymorphisms and the incidence of diabetic retinopathy among Japanese subjects with type 2 diabetes mellitus.

Authors:  Kazunori Morita; Junji Saruwatari; Haruna Miyagawa; Yoshihiro Uchiyashiki; Kentaro Oniki; Misaki Sakata; Ayami Kajiwara; Akira Yoshida; Hideaki Jinnouchi; Kazuko Nakagawa
Journal:  Cardiovasc Diabetol       Date:  2013-09-13       Impact factor: 9.951

7.  Synergistic association between two alcohol metabolism relevant genes and coronary artery disease among Chinese hypertensive patients.

Authors:  Yuefei Wang; Fengxia Du; Hongye Zhao; Xiaohong Yu; Jun Liu; Yu Xiao; Changzhu Lu; Xue Li; Yanli Wang; Bin Wang; Wenquan Niu
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

8.  The ALDH2 rs671 polymorphism affects post-stroke epilepsy susceptibility and plasma 4-HNE levels.

Authors:  Heng Yang; Zhi Song; Guo-Ping Yang; Bi-Kui Zhang; Min Chen; Tian Wu; Ren Guo
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

9.  Alcohol flushing is independently associated with lesser degree of carotid atherosclerosis in Japanese type 2 diabetic patients.

Authors:  Norimitsu Murai; Ryo Saiki; Mai Hashizume; Yasuyoshi Kigawa; Go Koizumi; Rie Tadokoro; Kei Endo; Toru Iizaka; Fumiko Otsuka; Masahiko Izumizaki; Shoichiro Nagasaka
Journal:  Diabetol Int       Date:  2017-07-28

10.  Exploring causal associations of alcohol with cardiovascular and metabolic risk factors in a Chinese population using Mendelian randomization analysis.

Authors:  Amy E Taylor; Feng Lu; David Carslake; Zhibin Hu; Yun Qian; Sijun Liu; Jiaping Chen; Hongbing Shen; George Davey Smith
Journal:  Sci Rep       Date:  2015-09-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.